Vimarsana
Biggest News Aggregation in the World

Page 32 - Expanded Access Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Expanded Access Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Expanded Access Program Today - Breaking & Trending Today

Vancouver organization launches first-ever paid, prescription fentanyl program - Vimarsana News

Vancouver organization launches first-ever paid, prescription fentanyl program

Patients in Vancouver will soon be able to access paid, prescription fentanyl that they can take home and use, an option the doctor leading the program says will allow people to escape "the violent system of trying to see your drug dealer and stay out of withdrawal every day."

RedHill Reports Potent Inhibition of Omicron with Oral COVID-19 Drug Candidate Opaganib In Vitro - Vimarsana News

RedHill Reports Potent Inhibition of Omicron with Oral COVID-19 Drug Candidate Opaganib In Vitro

- Oral opaganib's reported potent in vitro activity against Omicron adds to previously observed inhibition of Delta and other SARS-CoV-2 variants of concern...

Biophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives - Vimarsana News

Biophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives

Biophytis / Key word(s): Annual ResultsBiophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives 07-Apr-2022 / 08:00 CET/CESTBiophytis Announces 2021 Operational and Financial Results and Gives Updates on 2022 perspectives  Success of Nasdaq IPO in February 2021 €23.9M o...

Amylyx Pharmaceuticals Reports Full Year 2021 Financial Results - Vimarsana News

Amylyx Pharmaceuticals Reports Full Year 2021 Financial Results

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 30, 2022--

RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results - Vimarsana News

RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results

/PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported its operational...